timeline

The burning question i have never had answered is the time line to completion of phase11b/phase111 trials and then how long to commercialisation. Some on this forum have said 7 years, whilst some have said within 12-18 months because of potential orphan drug status and fast track approval from FDA.

Let me suggest to ALL the following, Some how gain access to the AVEXA COMPANY UPDATE (AVX) dated 17/04/2009.

I understand that we are looking at different drugs and differnet issues, but what stood out to me VERY clearly was the fact that AVX have been doing phase11b/phase111 testing for nearly 3 YEARS and they have stated they have fast track approval through the FDA.

Maybe some posters stating longer time frames are more on the money.

I am a long term believer, have been in since this time last year, only recently having sold down 2 thirds of my holdings to lock in some 5-600% gains. Whilst I still hold 1 third of my holdings and believe in CVAC I think this going to be a far longer process than most of us including myself originally anticipated.

This new funding facility whilst it looks to be a positive, I have some doubts about the share price ever achieving much more than short term ups and downs for a very very long time.

This is meant as a negative, however it is simply the thoughts that I have been dealing with and thought I would get them out of my head and to this forum.

I welcome all responses, negative or positive, but please back up your answers with information that can be substantiated, not just your personal feelings.